CLINICAL_TRIALS
trial_result
· 2024-09-03
Clinical Trial Update: Pembrolizumab in Elderly Patients With Advanced Lung Cancer [Phase 2]
Summary
Phase 2 clinical trial of pembrolizumab in elderly patients with advanced non-small cell lung cancer has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spanish Lung Cancer Group | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-09-03